Inventor · disambiguated record
Paroma Chakravarty
Also filed as: CHAKRAVARTY PAROMA
7 granted patents·3 pending applications·16 citations·filing 2013–2024
81Inventor score
Top patents by PatentIndex Score
10 records- 0193US11028100B2Polymorphs and solid forms of (s)-2-((2-((s)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide, and methods of productionGENENTECH INC·Filed 2020·Granted Jun 8, 2021·3 cites·25 claims
- 0287US10954234B2Solid forms of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3- fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their useGENENTECH INC·Filed 2019·Granted Mar 23, 2021·6 cites·81 claims
- 0386US9290458B2Amorphous form of an AKT inhibiting pyrimidinyl-cyclopentane compound, compositions and methods thereofGENENTECH INC·Filed 2013·Granted Mar 22, 2016·4 cites·44 claims
- 0483US11591345B2Polymorphs and solid forms of (s)-2-((2-((s)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide, and methods of productionGENENTECH INC·Filed 2020·Granted Feb 28, 2023·1 cites·18 claims
- 0582US9505725B2Crystalline and mesomorphous forms of an AKT inhibiting pyrimidinyl-cyclopentane compound, compositions and methods thereofGENENTECH INC·Filed 2016·Granted Nov 29, 2016·2 cites·17 claims
- 0680US2024409535A1Solid forms of 3-((1r,3r)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2h-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their useGENENTECH INC·Filed 2024·Application pending·0 cites
- 0779US12410189B2Polymorphs and solid forms of (S)-2-2((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9- yl)amino)propanamide, and methods of productionGENENTECH INC·Filed 2023·Granted Sep 9, 2025·0 cites·18 claims
- 0878US2024317738A1Solid forms of 3-((1r,3r)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2h-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their useGENENTECH INC·Filed 2023·Application pending·0 cites
- 0968US11780834B2Solid forms of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3- yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their useHOFFMANN LA ROCHE·Filed 2020·Granted Oct 10, 2023·0 cites·72 claims
- 1058US2018339997A1Polymorphs and solid forms of (s)-2-((2-((s)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide, and methods of productionGENENTECH INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paroma Chakravarty files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →